RxDoctor Payments Data

Michelle Purvis, MD

Family Medicine · Delta, CONPI 1871530113

Payments from drug & device makers

$1,840in general payments, 2019–2025

Across 93 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$783
  • AbbVie$304
  • GSK$242
  • Astellas Pharma US Inc$135
  • Vanda Pharmaceuticals Inc.$56
  • Amgen$53
  • plus $268 from 11 others

What the payments were for

  • Food & beverage$1,77596%
  • Education$654%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,840 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$176,628
Medicare patients
211
Services billed
5,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban25$40,589
OzempicSemaglutide22$29,282
EliquisApixaban25$29,227
FarxigaDapagliflozin Propanediol16$26,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$23,910
MyrbetriqMirabegron47$21,636
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$7,890
Repatha SyringeEvolocumab14$7,720
PremarinEstrogens, Conjugated11$5,708
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$4,926
Novolin 70-30Insulin Nph Hum/Reg Insulin Hm11$2,927
Potassium Chloride96$2,889
SymbicortBudesonide/Formoterol Fumarate12$2,866
Sucralfate45$2,477
Levothyroxine Sodium258$2,474

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$25$40,58925 claims
GSKTrelegy Ellipta, Anoro Ellipta$242$31,80033 claims
AstraZenecaFarxiga, Symbicort$783$29,57428 claims
Astellas Pharma US IncMyrbetriq$135$21,63647 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Delta

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →